VRFR- Immersive Virtual Reality Use in a Spine Functional Restoration Program - A Feasibility Study
VRFR
2 other identifiers
interventional
20
1 country
5
Brief Summary
This clinical trial investigates the feasibility of integrating immersive virtual reality (VR) technology into a functional restoration program (FRP) for patients with chronic low back pain (CLBP). The study aims to assess the acceptability, usability, and impact of a VR headset on both healthcare providers and patients participating in a group-based rehabilitation program. Chronic low back pain is a leading cause of functional disability worldwide and significantly impacts quality of life. Current rehabilitation strategies, including FRP, focus on improving physical functioning through multidisciplinary approaches. However, the role of emerging technologies, particularly VR, in enhancing these rehabilitation programs remains underexplored. VR has already shown promise in reducing chronic pain and improving motor abilities, but its application in a group rehabilitation context for CLBP is novel. The study will recruit healthcare providers and patients from several centers that are part of the Lombaction network. Participants will use a VR headset designed specifically to improve motor skills and reduce pain. The primary objective is to evaluate the acceptability of the VR device by healthcare providers and patients, as well as the usability and adherence to the VR program. Secondary objectives include assessing the impact of VR on kinesiophobia, pain, functional abilities, and motor imagery capabilities. This pilot study will provide valuable insights into the feasibility of incorporating VR into group-based rehabilitation programs, offering a foundation for larger comparative trials aimed at evaluating the long-term effectiveness of VR in improving rehabilitation outcomes for chronic low back pain.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2025
Typical duration for not_applicable
5 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 29, 2024
CompletedFirst Posted
Study publicly available on registry
December 9, 2024
CompletedStudy Start
First participant enrolled
March 19, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 19, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
April 19, 2027
ExpectedJune 17, 2025
June 1, 2025
1 year
November 29, 2024
June 12, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Acceptance of the VR system
a questionnaire based on the UTAUT 2 model
5 weeks (last day of Functional restoration program)
Secondary Outcomes (3)
Usability
5 weeks (last day of Functional restoration program)
Functional disability
day 1 and day 35 (First and Last day of the functional restauration program)
Patient pain
day 1 and day 35 (First and Last day of the functional restauration program) and during VR session (before and after session)
Study Arms (1)
Experimental
EXPERIMENTALInterventions
Patients participating will engage in three 20-minute VR sessions per week, in addition to the standard FRP program, for a duration of four to five weeks. The sessions will consist of a series of pre-programmed exercises designed to facilitate various trunk movements (flexion, extension, inclination, rotation) through exergames. Each exercise will last an average of 5 to 7 minutes. These exercises have been developed in collaboration between the company providing the VR device and the rehabilitation teams. Patients will be set up by a healthcare provider in a dedicated room for VR use. The provider will configure the device, assist the patient in donning it, and initiate the program, will remain present throughout the session to monitor for any adverse effect . While the specific exercises may vary, the total duration of the session will be 20 minutes, consisting of various exercises interspersed with breaks. The principal investigator will propose a standardized series of exercises,
Eligibility Criteria
You may qualify if:
- Caregivers involved in RFR programs at participating centers and likely to use the VR tool during the program.
- Consent of the caregiver to participate in the study.
- Aged between 18 and 65 years.
- Diagnosed with chronic low back pain lasting more than three months, with secondary causes excluded.
- Candidates for integration into an RFR program at one of the participating centers.
- Affiliated with or beneficiaries of a social security scheme.
- Provide informed consent to participate in the study
You may not qualify if:
- Presence of any other condition incompatible with the RFR program.
- Recent surgery or trauma (within the last month).
- Contraindications for using the VR device, including unstable epilepsy, facial trauma within the last three months, hearing or visual impairments, or previous experiences of pain, dizziness, or nausea triggered by VR device use.
- Visual impairments preventing the use of the VR device.
- Pregnancy or breastfeeding.
- Poor comprehension of the French language.
- Incarceration by judicial or administrative decision.
- Undergoing compulsory psychiatric treatment.
- Subject to legal protection measures.
- Incapable of providing informed consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (5)
Les capucins
Angers, 49103, France
CH Cholet
Cholet, 49325, France
CH Laval
Laval, 53015, France
CHU Rennes
Rennes, 35033, France
Centre Hospitalier Bretagne Atlantique - Site de vannes
Vannes, 56017, France
Related Publications (1)
Champagne R, Ali P, Ronzi Y, Dinomais M. Study protocol: use of virtual reality in a functional restoration programme for the spine-single-arm acceptance study. BMJ Open. 2025 Nov 26;15(11):e106366. doi: 10.1136/bmjopen-2025-106366.
PMID: 41298262DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Romain CHAMPAGNE, MD
Hospital, Laval
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 29, 2024
First Posted
December 9, 2024
Study Start
March 19, 2025
Primary Completion
March 19, 2026
Study Completion (Estimated)
April 19, 2027
Last Updated
June 17, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will not share